表紙:ガラクトオリゴ糖(GOS)の世界市場の評価:形状別、用途別、最終用途別、地域別、機会、予測(2016年~2030年)
市場調査レポート
商品コード
1394210

ガラクトオリゴ糖(GOS)の世界市場の評価:形状別、用途別、最終用途別、地域別、機会、予測(2016年~2030年)

Galacto-oligosaccharides Market Assessment, By Form, By Application, By End-use, By Region, Opportunities and Forecast, 2016-2030F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 203 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ガラクトオリゴ糖(GOS)の世界市場の評価:形状別、用途別、最終用途別、地域別、機会、予測(2016年~2030年)
出版日: 2023年12月08日
発行: Market Xcel - Markets and Data
ページ情報: 英文 203 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のガラクトオリゴ糖(GOS)の市場規模は、2022年の50.94キロトンから2030年までに78.18キロトンに達し、2023年~2030年の予測期間にCAGRで5.5%の成長が見込まれています。市場は、その成長と隆盛に寄与しているいくつかの重要な促進要因の影響を受けています。主な促進要因の1つは、腸内健康の重要性に対する意識の高まりです。消費者は現在、健康な腸内細菌叢が全体的なウェルビーイングにどのような影響を与えるかをより意識するようになり、GOSのようなプレバイオティック成分に対する高い需要につながっています。

機能性食品・飲料の人気の向上も、消費者が基本的な栄養を超えた健康利益を提供する製品を求めるようになり、GOSがこうした機能性アイテムに使用されることが多くなっているためです。さらに、ヒトミルクオリゴ糖(HMO)との類似性による乳児用調製粉乳へのGOSの使用が、乳児栄養セグメントにおける需要を促進しています。

さらに、プロバイオティックとプレバイオティック飲料を含む機能性飲料の開発がGOSの使用を拡大しています。これらの飲料は、消化器系の健康を増進する可能性があるとして人気を集めています。結論として、GOSの健康上の利点に関する進行中の調査と臨床研究からの肯定的な結果が、この成分の評判と需要の拡大に寄与していることから、調査と臨床研究がGOS市場の発展において重要な役割を果たしています。

ガラクトオリゴ糖(GOS)の使用を増加させるペット飼料の需要

ガラクトオリゴ糖(GOS)のペット飼料への利用は、ペットの健康と栄養の重要性に対する認識の高まりに後押しされ、注目されつつあります。GOSは、ペットの消化器系の健康増進に主眼を置き、ペットの腸内細菌叢をサポートし、消化を助け、胃腸障害の発生を減少させるなど、ペットにさまざまな利益をもたらします。さらに、GOSはペットの免疫システムを強化し、疾患に対する抵抗力を強化し、ペットのアレルギー反応を緩和する可能性を示しており、一般的なペットのアレルギーを管理するための貴重な成分としての地位を確立しています。

例えば、Nestle Purina PetCare Co. は、米国バージニア州キングウィリアム郡にあるペットケア製品の製造施設を拡張するため、1億8,200万米ドルを投資しました。製造の拡大とペット飼料の旺盛な需要が、ガラクトオリゴ糖(GOS)を世界中で強化します。

ガラクトオリゴ糖(GOS)の需要を高めるプレバイオティクス飲料の消費増加

ガラクトオリゴ糖(GOS)は、栄養補助食品産業において極めて重要な役割を果たしており、特に腸の健康をサポートするという潜在的な健康効果が広く宣伝されています。消化器系の健康への関心の高まりが、栄養補助食品部門におけるGOSの大きな需要を促進しています。さらに、栄養補助食品産業の躍進は、機能性飲料の開発に伴っています。これには、腸内マイクロバイオーム・バランスの改善を通じて全体的な健康増進を目指すプロバイオティクスやプレバイオティクスの飲料や食品のような一連の製品が含まれます。

例えば、2023年7月にFHIRST Living Sodaが飲料市場に参入し、腸の健康をサポートするプロバイオティクスとプレバイオティクスを独自にブレンドした、先駆的な完全天然の無糖飲料であることを示しました。世界中で機能性食品の発売が増加し、ガラクトオリゴ糖(GOS)の需要が増加しています。

医薬品用途におけるガラクトオリゴ糖(GOS)の統合の増加による需要の向上

GOSは、過敏性腸症候群(IBS)や炎症性腸疾患(IBD)などの症状を含む胃腸障害に関連する症状を緩和する可能性に注目した研究の対象となってきました。GOSは有益な腸内細菌の増殖を促進し、腸の健康増進と関連症状の軽減に役立つことが期待されています。胃腸障害への対応に加え、下痢の管理にも使用されます。そのため、経口補水液のような下痢を緩和するように設計された特定の医薬品の注目成分であり、特に乳幼児における有効性に焦点が当てられています。

例えば、2023年第1四半期、Johnson & Johnsonは米国での売上が約10%増加し、総額125億2,000万米ドルに達したという印象的な結果を報告しました。医薬品の販売の急増は、GOSの需要増に寄与すると予測されます。

当レポートでは、世界のガラクトオリゴ糖(GOS)市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 世界のガラクトオリゴ糖(GOS)市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 顧客の声

  • 市場の認知度と製品情報
  • ブランドの認知度とロイヤルティ
  • 購入決定において考慮される要素
  • 購入頻度
  • 購入媒体

第6章 世界のガラクトオリゴ糖(GOS)市場の見通し(2016年~2030年)

  • 市場規模と予測
    • 金額
    • 数量
  • 形状別
    • 液体
    • 粉末
  • 用途別
    • プレバイオティクス
    • 甘味料
    • 動物飼料
    • その他
  • 最終用途別
    • 食品・飲料
    • 製薬
    • 化粧品・パーソナルケア
    • 畜産
    • その他
  • 地域別
    • 北米
    • 欧州
    • 南米
    • アジア太平洋
    • 中東・アフリカ
  • 市場シェア:企業別(2022年)

第7章 世界のガラクトオリゴ糖(GOS)市場の見通し:地域別(2016年~2030年)

  • 北米
    • 市場規模と予測
    • 形状別
    • 用途別
    • 最終用途別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • 南米
    • ブラジル
    • アルゼンチン
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第8章 サプライサイド分析

  • 生産能力:企業別
  • 生産:企業別
  • 運転効率:企業別
  • 主なプラントの所在地(最大25)

第9章 市場マッピング(2022年)

  • 形状別
  • 用途別
  • 最終用途別
  • 地域別

第10章 マクロ環境と産業構造

  • 需給分析
  • 輸出入の分析 - 数量と金額
  • サプライ/バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第11章 市場力学

  • 成長促進要因
  • 成長抑制要因(課題、抑制要因)

第12章 主要企業情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析(2022年)
  • 合併と買収/合弁事業(該当する場合)
  • SWOT分析(市場参入企業5社)
  • 特許分析(該当する場合)

第13章 価格分析

第14章 ケーススタディ

第15章 主要企業の見通し

  • Nissin Sugar Co., Ltd
  • Clasado Biosciences
  • Ingredion
  • Yakult Pharmaceutical Industry Co., Ltd
  • FrieslandCampina
  • Taiwan Fructose Co., Ltd
  • Dairy Crest Limited (Saputo Dairy UK)
  • VITALUS NUTRITION INC
  • Quantum Hi-Tech China Biological
  • King-Prebiotics Biotechnology (TW) Co., Ltd

第16章 戦略的推奨事項

第17章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 2. Global Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 3. Global Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 4. Global Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 5. Global Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 6. Global Galacto-oligosaccharides Market Share, By Region, in USD Billion, 2016-2030F
  • Figure 7. North America Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 8. North America Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 9. North America Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 10. North America Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 11. North America Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 12. North America Galacto-oligosaccharides Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 13. United States Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 14. United States Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 15. United States Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 16. United States Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 17. United States Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 18. Canada Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 19. Canada Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 20. Canada Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 21. Canada Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 22. Canada Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 23. Mexico Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 24. Mexico Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 25. Mexico Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 26. Mexico Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 27. Mexico Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 28. Europe Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 29. Europe Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 30. Europe Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 31. Europe Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 32. Europe Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 33. Europe Galacto-oligosaccharides Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 34. Germany Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 35. Germany Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 36. Germany Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 37. Germany Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 38. Germany Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 39. France Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 40. France Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 41. France Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 42. France Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 43. France Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 44. Italy Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 45. Italy Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 46. Italy Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 47. Italy Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 48. Italy Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 49. United Kingdom Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 50. United Kingdom Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 51. United Kingdom Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 52. United Kingdom Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 53. United Kingdom Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 54. Russia Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 55. Russia Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 56. Russia Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 57. Russia Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 58. Russia Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 59. Netherlands Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 60. Netherlands Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 61. Netherlands Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 62. Netherlands Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 63. Netherlands Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 64. Spain Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 65. Spain Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 66. Spain Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 67. Spain Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 68. Spain Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 69. Turkey Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 70. Turkey Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 71. Turkey Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 72. Turkey Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 73. Turkey Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 74. Poland Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 75. Poland Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 76. Poland Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 77. Poland Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 78. Poland Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 79. South America Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 80. South America Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 81. South America Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 82. South America Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 83. South America Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 84. South America Galacto-oligosaccharides Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 85. Brazil Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 86. Brazil Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 87. Brazil Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 88. Brazil Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 89. Brazil Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 90. Argentina Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 91. Argentina Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 92. Argentina Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 93. Argentina Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 94. Argentina Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 95. Asia-Pacific Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 96. Asia-Pacific Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 97. Asia-Pacific Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 98. Asia-Pacific Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 99. Asia-Pacific Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 100. Asia-Pacific Galacto-oligosaccharides Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 101. India Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 102. India Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 103. India Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 104. India Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 105. India Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 106. China Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 107. China Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 108. China Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 109. China Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 110. China Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 111. Japan Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 112. Japan Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 113. Japan Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 114. Japan Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 115. Japan Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 116. Australia Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 117. Australia Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 118. Australia Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 119. Australia Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 120. Australia Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 121. Vietnam Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 122. Vietnam Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 123. Vietnam Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 124. Vietnam Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 125. Vietnam Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 126. South Korea Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 127. South Korea Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 128. South Korea Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 129. South Korea Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 130. South Korea Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 131. Indonesia Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 132. Indonesia Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 133. Indonesia Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 134. Indonesia Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 135. Indonesia Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 136. Philippines Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 137. Philippines Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 138. Philippines Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 139. Philippines Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 140. Philippines Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 141. Middle East & Africa Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 142. Middle East & Africa Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 143. Middle East & Africa Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 144. Middle East & Africa Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 145. Middle East & Africa Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 146. Middle East & Africa Galacto-oligosaccharides Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 147. Saudi Arabia Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 148. Saudi Arabia Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 149. Saudi Arabia Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 150. Saudi Arabia Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 151. Saudi Arabia Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 152. UAE Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 153. UAE Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 154. UAE Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 155. UAE Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 156. UAE Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 157. South Africa Galacto-oligosaccharides Market, By Value, in USD Billion, 2016-2030F
  • Figure 158. South Africa Galacto-oligosaccharides Market, By Volume, in Kilotons, 2016-2030F
  • Figure 159. South Africa Galacto-oligosaccharides Market Share, By Form, in USD Billion, 2016-2030F
  • Figure 160. South Africa Galacto-oligosaccharides Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 161. South Africa Galacto-oligosaccharides Market Share, By End-use, in USD Billion, 2016-2030F
  • Figure 162. By Form Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 164. By End-use Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022
目次
Product Code: MX10709

Global galacto-oligosaccharides market size was recorded at 50.94 kilotons in 2022, which is expected to grow to 78.18 kilotons in 2030 with a CAGR of 5.5%, during the forecast period between 2023 and 2030. The galacto-oligosaccharides market is influenced by several key drivers that have contributed to its growth and prominence. One of the primary drivers is the increasing awareness of the importance of gut health. Consumers are now more conscious of how a healthy gut microbiome can impact overall well-being, which has led to a higher demand for prebiotic ingredients, like GOS.

The rising popularity of functional foods and beverages is another significant driver as consumers seek products that offer health benefits beyond basic nutrition, and GOS is often used in these functional items. Additionally, the use of GOS in infant formula due to its similarity to human milk oligosaccharides (HMOs) has propelled demand in the infant nutrition segment.

Moreover, the development of functional beverages, including probiotic and prebiotic drinks, has expanded the use of GOS. These beverages have gained popularity for their potential to enhance digestive health. Conclusively, Research and clinical studies have played a significant role in advancing the GOS market as ongoing research into the health benefits of GOS and positive results from clinical studies have contributed to the growing reputation and demand for this ingredient.

Demand for Pet Feed to Increase the use of Galacto-oligosaccharides

The utilization of Galacto-oligosaccharides (GOS) in pet feed is gaining prominence, driven by the growing recognition of the significance of pet health and nutrition. GOS offers a range of benefits for pets, with a primary focus on enhancing their digestive health, and supports the pet's gut microbiome, aids in digestion, and diminishing the occurrence of gastrointestinal issues. Moreover, GOS has demonstrated its potential in fortifying the immune system of pets, bolstering their resistance to diseases and serve to mitigate allergic reactions in pets, thus establishing itself as a valuable ingredient for the management of common pet allergies.

For instance, Nestle Purina PetCare Co. allocated an investment of USD 182 million to expand its manufacturing facility for pet care products in King William County, Virginia, the United States. Expansion of manufacturing and strong demand for pet feed to strengthen the Galacto-oligosaccharides globally.

Increasing Consumption of Prebiotics Drinks to Heighten Galacto-oligosaccharides Demand

Galacto-oligosaccharides play a pivotal role in the dietary supplements industry, where it is widely promoted for its potential health benefits, particularly in supporting gut health. The increasing focus on digestive well-being has driven significant demand for GOS within the dietary supplements sector. Moreover, the surge in the dietary supplements industry has been accompanied by the development of functional beverages. It includes a range of products like probiotic and prebiotic drinks and foods that aim to enhance overall health through improved gut microbiome balance.

For instance, during July 2023, FHIRST Living Soda entered the beverage market, marking the pioneering all-natural, sugar-free drink that uniquely blends probiotics and prebiotics to support gut health. The rise in launches of functional foods across the globe increases the demand for galacto-oligosaccharides.

Rising Integration of Galacto-oligosaccharides in Pharmaceutical Application to Improve Demand

GOS has been the subject of research focused on its potential to mitigate symptoms associated with gastrointestinal disorders, including conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). GOS fosters the proliferation of beneficial gut bacteria and has shown promise and helps in enhancing gut health and diminishing associated symptoms. In addition to addressing gastrointestinal disorders, it is used for managing diarrhea. Therefore, it is a featured ingredient in specific pharmaceutical products, such as oral rehydration solutions, designed to alleviate diarrhea, with a particular focus on its efficacy in infants and young children.

For instance, during Q1 of 2023, Johnson & Johnson reported impressive results in their sales experiencing a robust upswing of nearly 10 percent in the United States, reaching a total of USD 12.52 billion. The upsurge in sales of pharmaceuticals is expected to contribute to rising demand for GOS.

Impact of COVID-19

The galacto-oligosaccharides market experienced significant disruption due to the outbreak of COVID-19. Although the pandemic had a relatively milder impact on the food and beverage industry compared to other sectors, it severely affected the industry's global supply chain, constraining its growth potential. The shift in consumer behavior during this time had a detrimental effect on purchasing patterns, resulting in several challenges, including operational halts, hindrances to business expansion, and suspended activities. However, on the other hand, the lockdown heightened demand for GOS in few applications as the need for pet feed and prebiotic drinks increased during the pandemic.

Key Outlook

A huge percentage of the population of people across the globe is lactose intolerant, which is a major restrain to the market. However, the development of plant-based GOS will witness a consumption increase within this population.

The ongoing research of GOS in pharmaceuticals along with growing awareness of gut health will improve the demand for galacto-oligosaccharides market globally.

Key Players Landscape and Outlook

Key players in the galacto-oligosaccharide market are actively involved in the creation of innovative products, primarily intended to function as dietary supplements. This strategic initiative is coordinated with the increasing worldwide need for nutritional supplements and the industry's adaptability to changing consumer preferences in this regard. It underscores a dedication in addressing the rising market requirements for health-oriented products, emphasizing a pivotal role of galacto-oligosaccharide in modern dietary solutions.

For instance, in August 2022, FrieslandCampina Ingredients created a specialized prebiotic with the aim of spurring innovation in the expanding market for gut health supplements. Featuring an exceptionally high galacto-oligosaccharide content of more than 90%, Biotis GOS-OP High Purity stands as the company's most refined prebiotic ingredient.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on Global Galacto-oligosaccharides Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Market Awareness and Product Information
  • 5.2. Brand Awareness and Loyalty
  • 5.3. Factors Considered in Purchase Decision
    • 5.3.1. Brand Name
    • 5.3.2. Quality
    • 5.3.3. Quantity
    • 5.3.4. Price
    • 5.3.5. Product Specification
    • 5.3.6. Application Specification
    • 5.3.7. VOC/Toxicity Content
    • 5.3.8. Availability of Product
  • 5.4. Frequency of Purchase
  • 5.5. Medium of Purchase

6. Global Galacto-oligosaccharides Market Outlook, 2016-2030F

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
    • 6.1.2. By Volume
  • 6.2. By Form
    • 6.2.1. Liquid
    • 6.2.2. Powder
  • 6.3. By Application
    • 6.3.1. Prebiotic
    • 6.3.2. Sweetener
    • 6.3.3. Animal feed
    • 6.3.4. Others
  • 6.4. By End-use
    • 6.4.1. Food and Beverages
      • 6.4.1.1. Dietary supplements
      • 6.4.1.2. Dairy products
      • 6.4.1.3. Bakery products
      • 6.4.1.4. Others
    • 6.4.2. Pharmaceutical
    • 6.4.3. Cosmetic and Personal care
    • 6.4.4. Animal Husbandry
    • 6.4.5. Others
  • 6.5. By Region
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. South America
    • 6.5.4. Asia-Pacific
    • 6.5.5. Middle East and Africa
  • 6.6. By Company Market Share (%), 2022

7. Global Galacto-oligosaccharides Market Outlook, By Region, 2016-2030F

  • 7.1. North America*
    • 7.1.1. Market Size & Forecast
      • 7.1.1.1. By Value
      • 7.1.1.2. By Volume
    • 7.1.2. By Form
      • 7.1.2.1. Liquid
      • 7.1.2.2. Powder
    • 7.1.3. By Application
      • 7.1.3.1. Prebiotic
      • 7.1.3.2. Sweetener
      • 7.1.3.3. Animal feed
      • 7.1.3.4. Others
    • 7.1.4. By End-use
      • 7.1.4.1. Food and Beverages
      • 7.1.4.1.1. Dietary supplements
      • 7.1.4.1.2. Dairy products
      • 7.1.4.1.3. Bakery products
      • 7.1.4.1.4. Others
      • 7.1.4.2. Pharmaceutical
      • 7.1.4.3. Cosmetic and Personal care
      • 7.1.4.4. Animal Husbandry
      • 7.1.4.5. Others
    • 7.1.5. United States*
      • 7.1.5.1. Market Size & Forecast
      • 7.1.5.1.1. By Value
      • 7.1.5.1.2. By Volume
      • 7.1.5.2. By Form
      • 7.1.5.2.1. Liquid
      • 7.1.5.2.2. Powder
      • 7.1.5.3. By Application
      • 7.1.5.3.1. Prebiotic
      • 7.1.5.3.2. Sweetener
      • 7.1.5.3.3. Animal feed
      • 7.1.5.3.4. Others
      • 7.1.5.4. By End-use
      • 7.1.5.4.1. Food and Beverages
      • 7.1.5.4.1.1. Dietary supplements
      • 7.1.5.4.1.2. Dairy products
      • 7.1.5.4.1.3. Bakery products
      • 7.1.5.4.1.4. Others
      • 7.1.5.4.2. Pharmaceutical
      • 7.1.5.4.3. Cosmetic and Personal care
      • 7.1.5.4.4. Animal Husbandry
      • 7.1.5.4.5. Others

All segments will be provided for all regions and countries covered:

    • 7.1.6. Canada
    • 7.1.7. Mexico
  • 7.2. Europe
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. Italy
    • 7.2.4. United Kingdom
    • 7.2.5. Russia
    • 7.2.6. Netherlands
    • 7.2.7. Spain
    • 7.2.8. Turkey
    • 7.2.9. Poland
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
  • 7.4. Asia-Pacific
    • 7.4.1. India
    • 7.4.2. China
    • 7.4.3. Japan
    • 7.4.4. Australia
    • 7.4.5. Vietnam
    • 7.4.6. South Korea
    • 7.4.7. Indonesia
    • 7.4.8. Philippines
  • 7.5. Middle East & Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. South Africa

8. Supply Side Analysis

  • 8.1. Capacity, By Company
  • 8.2. Production, By Company
  • 8.3. Operating Efficiency, By Company
  • 8.4. Key Plant Locations (Up to 25)

9. Market Mapping, 2022

  • 9.1. By Form
  • 9.2. By Application
  • 9.3. By End-use
  • 9.4. By Region

10. Macro Environment and Industry Structure

  • 10.1. Supply Demand Analysis
  • 10.2. Import Export Analysis - Volume and Value
  • 10.3. Supply/Value Chain Analysis
  • 10.4. PESTEL Analysis
    • 10.4.1. Political Factors
    • 10.4.2. Economic System
    • 10.4.3. Social Implications
    • 10.4.4. Technological Advancements
    • 10.4.5. Environmental Impacts
    • 10.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 10.5. Porter's Five Forces Analysis
    • 10.5.1. Supplier Power
    • 10.5.2. Buyer Power
    • 10.5.3. Substitution Threat
    • 10.5.4. Threat from New Entrant
    • 10.5.5. Competitive Rivalry

11. Market Dynamics

  • 11.1. Growth Drivers
  • 11.2. Growth Inhibitors (Challenges, Restraints)

12. Key Players Landscape

  • 12.1. Competition Matrix of Top Five Market Leaders
  • 12.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
  • 12.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 12.4. SWOT Analysis (For Five Market Players)
  • 12.5. Patent Analysis (If Applicable)

13. Pricing Analysis

14. Case Studies

15. Key Players Outlook

  • 15.1. Nissin Sugar Co., Ltd
    • 15.1.1. Company Details
    • 15.1.2. Key Management Personnel
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As reported)
    • 15.1.5. Key Market Focus & Geographical Presence
    • 15.1.6. Recent Developments
  • 15.2. Clasado Biosciences
  • 15.3. Ingredion
  • 15.4. Yakult Pharmaceutical Industry Co., Ltd
  • 15.5. FrieslandCampina
  • 15.6. Taiwan Fructose Co., Ltd
  • 15.7. Dairy Crest Limited (Saputo Dairy UK)
  • 15.8. VITALUS NUTRITION INC
  • 15.9. Quantum Hi-Tech China Biological
  • 15.10. King-Prebiotics Biotechnology (TW) Co., Ltd

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us & Disclaimer